13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>of</strong> methotrexate induced nephropathy includes brisk,diuresis alkalinization <strong>of</strong> the urine to keep the urinarypH above 7.0 and monitoring serum creatinine andmethotrexate levels (13).6. Bleomycin : Bleomycin does not directly cause renaltoxicity. It is excreted primarily by the kidneys, so doseadjustment is required in the presence <strong>of</strong> renalinsufficiency or failure.7. Bevacizumab: It may induce nephrotic proteinuria andsevere hypertension If a treated patient develops morethan moderate proteinuria without the nephroticsyndrome, then the drug should be temporarily held asthe proteinuria generally resolves (14).8. Bisphosphonates : Pamidronate and zoledronic acid arecommonly used Both drugs undergo renal excretion.Pamidronate should not be administered in the presence<strong>of</strong> severe renal impairment or if the serum creatininerises more than 0.5 mg per dL during treatment (15).Zoledronic acid may be dosed based on CCR (16).Table 1 Chemotherapeutic Drugs not Requiring DoseModification in Renal Failure (17)Actinomycin D Gemcitabine TeniposideAmsacrine Idarubicin 6-ThioguanineBusulfan Melphalan (p.o.) ThiotepaChlorambucil 6-Mercaptopurine VinblastineDaunorubicin Mitoxantrone VincristineDocetaxel Paclitaxel VindesineDoxorubicin Procarbazine Vinorelbine5-Fluorouracil450

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!